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Summary Objective: The aim of this study was to evaluate the epidemiology of cu-
taneous leishmaniasis in the Eastern Province of Saudi Arabia. In addition, the clinical
spectrum of the disease was evaluated.
Methods: This is a retrospective study of cutaneous leishmania cases from 1956 to
2002.
Results: In the study period, there were 1862 patients with cutaneous leishmaniasis
in the Saudi Aramco health care system. The disease is more prevalent in the Al-Hasa
Oasis (Eastern Province of Saudi Arabia) and affects males and females equally. Cuta-
neous leishmaniasis follows a seasonal distribution in parallel with the known activity
of the sandﬂy. The majority (76%) of cases occurred in patients <15 years of age and
the disease affected the extremities more frequently than the face. Seventy-one per-
cent of patients presented with a single lesion and 27% presented with two lesions.
Ulcerative cutaneous leishmaniasis was the predominant morphology (89%).
Conclusion: Cutaneous leishmaniasis attained epidemic proportions in 1973 and
subsequently declined and reached a plateau in themid-1980s. Skin involvement is the
major clinical picture, with no evidence of dissemination or viscerotropic syndrome.
© 2004 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Introduction
Cutaneous leishmaniasis (CL) is endemic in some
countries in the Middle East, on the Mediterranean
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coast and in central Asia.1 The disease was ﬁrst
described in Saudi Arabia in 1973 by Moursy and
Shoura.2 Cutaneous leishmaniasis is endemic in the
Eastern Province of Saudi Arabia, mainly in the
Al-Hasa Oasis. The oasis of Al-Hasa is located ap-
proximately 175 km south of the cities of Dammam
and Dhahran and 60 km west of the coast of the
Arabian Gulf. The main city of the Al-Hasa Oasis
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Figure 1 Map of Saudi Arabia showing the geographic location of Hofuf (arrow), the largest city of the Al-Hasa Oasis.
is Hofuf (Figure 1). The Al-Hasa Oasis is very hot
in the summer (maximum 49 ◦C) and cool in the
winter (minimum 1 ◦C).3 The vector of the dis-
ease is the sandﬂy (Phlebotomous papatasis)4 and
the natural hosts are desert rodents (Meriones
libycus and M. crassus).3 Leishmania tropica, the
causative agent of cutaneous leishmaniasis in the
Al-Hasa Oasis, classically causes skin lesions with-
out dissemination. However, it has been reported
that L. tropica may cause the mucocutaneous form
of leishmania5 and viscerotropic leishmaniasis has
been described in returning troops from the Desert
Storm operation during the Gulf War.6—8
The disease is locally known as Okhet (sister),
Nafra (the rash), Domal (boil), and El-Mohtafura
(the digger).9 In an earlier study, a total of 122 pa-
tients were evaluated and the difference between
Saudi and non-Saudi patients were described.9
In that study, Saudi patients were younger and
had signiﬁcantly milder forms of the disease com-
pared to non-Saudi patients.9 In another, smaller
study, 16 of 73 (22%) patients with CL had dissem-
inated disease.10 Involvement of lymph nodes in
patients with CL has also been described in 10%
of 643 patients.11 Other studies have described
different aspects of the disease in a non-immune
population.12 In addition, there are studies deal-
ing with in vitro identiﬁcation of the leishmania
parasite from man, wild animals and sandﬂies.13
However, most of the epidemiological and clinical
data in these studies relied on a small number of
patients. Thus, the largest number of CL patients
are reported in this study and the epidemiology of
the disease is discussed in the Eastern Province of
Saudi Arabia over a 46-year period.
Methods
This is a retrospective study of the epidemiology
of CL in the Saudi Aramco Health Care Population
(SAHCP). Saudi Aramco Medical Services Organiza-
tion (SAMSO) provides medical care and currently
covers 370,000 Saudi Aramco employees and their
dependents.
Epidemiological data for the years 1956 to 1991
were collected from the communicable disease re-
porting system. The data have been systematically
collected since 1956 and have been computerized
since 1983. All reports of CL were initiated by
SAMSO physicians and/or laboratory technicians.
From 1992 to 2002, additional clinical data were
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also available from standardized leishmania inves-
tigation forms. The data included the demographic
information, clinical manifestations, and treat-
ments. Data were entered in a Microsoft Access
2000 ﬁle and were analyzed with Epi Info (V 6.02,
CDC). Thus, the geographic location, clinical pre-
sentation and treatment were analyzed only for
a subset of patients for whom those data were
available.
Results
Number of cases
During the period 1956 to 1991, 1255 cases of
CL were identiﬁed. An additional 607 cases of CL
were obtained from 1992 to 2002. There were no
repeated cases among these 1862 patients. The
number of cases per year markedly increased from
ﬁve cases in the 1950s—60s, to 80 cases in the
1970s—80s, and 50 cases per year in the 1990s
(Figure 2). Although there were approximately 120
cases reported in 1996, the incidence has been
stable at about 20 to 40 per 100,000 since 1987.
Gender and age distribution
Patients’ ages ranged from six months to 83 years.
The median age was seven years and the mean
(±SD) was 10.9± 13.5 years. The number of cases
by age group is shown in Figure 3 for the total
period from 1956 to 2002. The majority (76%) of
cases occurred in individuals <15 years of age. The
number of cases and the rate per 100,000 popu-
Figure 2 Cutaneous leishmaniasis in Saudi Aramco Health Care Population between 1956 and 2002. The histogram
shows the number of new cases of cutaneous leishmaniasis per year (bars) and the yearly rate of cases (line graph).
lation reached a peak in the age group between
one and four years of age, and declined thereafter.
The lowest rate was found in patients between the
ages of 60 and 69 years. Both males and females
were affected equally (1.1:1). Almost all patients
(98.3%) were Saudis.
Geographic location (1992—2002)
The geographic location of patients was available
for the period 1992—2002. The majority (93%) of
cases occurred in the Al-Hasa region, 4% of cases
occurred in the Abqaiq area, and eight cases (2%)
in the city of Ras Tanura; these eight patients had
frequently travelled to the Al-Hasa region. In the
Al-Hasa Oasis, most cases occurred in the towns of
Hofuf (27%) and Mubaraz (18%) (Figure 1).
Seasonal distribution (1980—2002)
The number of reported cases increased in Septem-
ber, remained high in the following months, and
reached its peak in January and February (Figure 4).
The number of patients then began to decline in
March and reached its lowest number between April
and July.
Clinical presentations (1992—2002)
Clinical data were available for patients from
1992 to 2002. A total of 607 cases of CL were re-
ported during this time period. Patients usually
presented to physicians late after the onset. Of
294 patients for whom an accurate time of onset
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Figure 3 Age and sex distribution of cutaneous leishmaniasis from 1956—2002. The histogram shows the number of
new cases of cutaneous leishmaniasis (bars) in each age group and the rate of cases (line graph) in the age groups.
of lesions was recorded, 162 (55%) presented one
to two months after the onset of their skin lesions
(Table 1).
The anatomical distribution of skin lesions is
shown in Figure 5. The most frequently affected
sites were the face (36%), upper limbs (33%), and
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Figure 4 Month-by-month mean number of cases of cutaneous leishmaniasis for the periods 1980—1991 and
1992—2002.
lower limbs (32%). Skin lesions in male children
(<4 years of age) were often located on the face
(62%), whereas 36% of females in the same age
group had lesions in the face (Figure 5). Adults had
most lesions on the limbs and fewer lesions on the
face (Figure 5). It is interesting to note that adult
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Table 1 Duration of skin lesions prior to presenta-
tion to physicians.
Age group Delay in time prior to clinic visit
<1 month 1—2 months ≥3 months
0—4 34 64 13
5—9 32 44 7
10—14 12 30 9
15+ 15 24 10
Total 93 162 39
males and females were almost identical in the
pattern of involvement of the different parts of
the body.
Of the 607 cases, 431 (71%) patients had a single
lesion, 169 (27%) patients had two lesions and the
remaining 2% had ≥3 lesions (Figure 6). There was
no signiﬁcant difference in the number of skin le-
sions between the different age groups. Cutaneous
leishmaniasis presents with 3 patterns of skin le-
sions. The most common identiﬁable morphology
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Figure 5 Anatomical distribution of cutaneous leishmaniasis lesions by age groups (F = Females; M = Males).
Figure 6 Distribution of number of cutaneous leishmaniasis lesions per patient in different age groups.
Table 2 Distribution of cutaneous leishmaniasis
according to smear results and site of infection
(1992—2002).
Location Positive Negative Total % Pos
Face 140 95 235 60%
Arms 134 66 200 67%
Legs 94 35 129 72%
Total 368 196 564 65%
(P-value = 0.05, χ2 = 7.91).
was the ulcerative type (89.5%), whereas nodules
constituted 9.5% of lesions and the remaining 1%
were nodulo-ulcerative in nature.
Diagnosis
The most commonly used laboratory technique
for the diagnosis of CL was stained smears. Of
564 examined smears, 368 (65%) were positive for
the leishmania parasite. The remaining 196 (35%)
smears were negative. Table 2 shows the smear
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results in relation to the anatomical site of infec-
tion. No information on parasitological cultures
and no zymodeme characterization was available
in this retrospective study.
Treatment
Of the 424 patients who received their treatment at
SAMSO clinics, 373 (88%) patients received sodium
stibogluconate and the other patients received al-
ternative medications (either ketoconazole or itra-
conazole). A single course of intramuscular sodium
stibogloconate for 28 days resulted in elimination of
the disease in 239 of the 373 (64%) patients. There
was no difference in the response to sodium sti-
bogloconate in patients with positive and negative
leishmania smears (data not shown).
Discussion
Cutaneous leishmaniasis has been reported in the
Arabian peninsula since 1973.14 However, this is
the largest reported epidemiological study of CL
in the Eastern Province of Saudi Arabia. The dis-
ease reached epidemic proportions in 1973 when
the number of CL cases totaled 90, a rate of
100/100,000 population. A deﬁnite ﬂuctuation
in the total number of cases per year is evident
(Figure 2); however, the rate per 100,000 Saudi
Aramco Health Care Population has stabilized since
the late 1980s. The reason for such an increase may
be related to increased detection and awareness
of CL. However, continued environmental changes
in the 1970s and 1980s have provided a rapid popu-
lation shift and/or an increase in contact between
humans and sandﬂies. Subsequently, social and
economic stabilization resulted in a plateau of the
rate of CL in the Al-Hasa Oasis. In addition, contin-
ued efforts to eradicate CL from the Al-Hasa Oasis
have contributed signiﬁcantly to the decline in the
number of cases.
The data clearly conﬁrm earlier reports that CL
affects both sexes equally.9,15 This ﬁnding of equal
involvement of both males and females is interest-
ing, since Saudi females cover their bodies. How-
ever, the majority of cases were <15 years of age,
not adults. Second, the most frequently affected
sites are the legs in females and not the face (Figure
5). Third, only 85% of CL lesions were located on
exposed areas as reported in an early study.16 The
data also show that all age groups are susceptible
to infection with leishmania. However, it is inter-
esting to note that those between the ages of one
and four years are affected more frequently than
other age groups in our population (Figure 3). In
contrast, a study of 33 patients with CL in Kuwait
showed that CL occurs in patients between the ages
of 21 and 30 years more often than in other age
groups.15 Our study is much larger, however, and
is population based. The high attack rate of CL in
children between one and four years in our study
may be explained on the basis that these individu-
als do not have any immunity against CL. With the
exposure of young people to CL and the develop-
ment of active immunity, there is a decline in the
rate of infection. Complete recovery from CL may
be associated with resistance to re-infection by the
homologous Leishmania species.17
Skin lesions from CL were located almost equally,
on the upper limbs, lower extremities and the face
(Figure 5). Previous descriptions of the disease indi-
cated that extremities were more often involved in
CL than the face.15,18 This ﬁnding may be explained
by the fact that sandﬂies usually travel close to the
groundwhere they can easily bite the lower extrem-
ities. In addition, sleeping outdoors and the expo-
sure of extremities may encourage sandﬂies to bite
during the night.15 Outdoor activities between dusk
and dawn increase the transmission of CL.19
In this study, most patients with CL had single le-
sions (70—80%) and <5% had multiple lesions. This
ﬁnding is in contrast to previous reports, which have
indicated that most patients (78%) with CL had mul-
tiple lesions.3,15 However, Al-Gindan et al. reported
that 53% of Saudis and only 6% of non-Saudis had
single skin lesions.9 Partial immunity to the homol-
ogous Leishmania spp and the presence of cryptic
(unrecognized) infection may have contributed to
this ﬁnding.9
The seasonal pattern of the disease correlates
with the known activity of the vector.3,9,15 There
is usually a lag time from the development of skin
lesions to the presentation of patients to physicians.
This lag in time explains the difference in timing
between the peak activity of the sandﬂy in April
and September and the peak of cases in September
and January.9,19
Treatment of CL may include heat, cryotherapy,
surgical excision and chemotherapy with antimonial
compounds, ketoconazole, itraconazole or ampho-
tericin B.20,21 Eighty-eight percent of our patients
received the standard treatment for CL with sodium
stibogluconate and it was curative in themajority of
patients. Ketoconazole and itraconazole were used
less frequently than sodium stibogluconate and so
it was not possible to judge the efﬁcacy of these
agents in the treatment of CL in this study.
Conclusion
In conclusion, CL in the Al-Hasa Oasis attained
epidemic proportions in 1973 and subsequently
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declined and reached a plateau in the mid-1980s.
Skin involvement is the major clinical picture, with
no evidence of dissemination or viscerotopic syn-
drome.
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